HONOLULU — In patients with Barrett's esophagus, low-grade dysplasia carries a substantial risk for progression to esophageal adenocarcinoma, investigators report. The risk for progression in patients ...
Despite updated guidelines, substantial variation remains in how expert gastroenterologists manage Barrett esophagus, ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a patient ...
Bethesda, MD (May 17, 2024) — The American Gastroenterological Association’s (AGA) new evidence-based Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a new study published in The ...
Testing for somatic genomic copy number alterations (CNAs) in ulcerative colitis patients with low-grade dysplasia was able to predict risk of advanced neoplasia more accurately than other currently ...
The esophagus is the tube that connects your mouth to your stomach. Barrett’s esophagus is a condition where the tissue in your lower esophagus becomes damaged. It starts to resemble the tissue in ...
A phase Ib/II study of fruquintinib in combination with SOX and toripalimab as first-line treatment for advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC). Infusional ...
Strong recommendation for EET in patients with BE high-grade dysplasia based on available evidence. HealthDay News — In a clinical practice guideline issued by the American Gastroenterological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback